In-stent restenosis (ISR) is a common clinical problem in patients with coronary artery
disease treated with percutaneous coronary intervention. Inflammatory process plays a …

OBJECTIVES: We hypothesized that a higher degree of inflammatory response to coronary
stenting, as measured by the change in C-reactive protein (CRP) levels after intervention in …

Patients without traditional cardiovascular risk factors continue to suffer from cardiovascular
events, which has prompted a search for novel markers to better assess cardiovascular risk …

Aims The acute phase reactant C-reactive protein is an important prognostic risk factor in
patients with both stable and unstable coronary artery disease. The potential prognostic …

Objective: In this study we evaluate the value of baseline concentrations of acute-phase
reactants on prognosis after percutaneous coronary intervention (PCI). Methods: Blood …

Recent research suggests that inflammation in the coronary arteries may be intimately
involved in the development of atherosclerosis and its associated acute coronary …

The introduction of percutaneous coronary interventions (PCI) with stent implant has
substantially shifted the treatment of coronary artery disease. The current approach to …

Background: Progression of nontarget lesions (NTLs) after percutaneous coronary
intervention (PCI) has been reported. However, it remains unknown whether progression of …

Background Stroke is a heterogeneous disease with several risk factors. High sensitivity C-
reactive protein (hsCRP) is a marker for cardiovascular and cerebrovascular diseases …

BACKGROUND: Statin pretreatment before percutaneous coronary intervention (PCI) is
associated with a reduced incidence of short-term adverse events and periprocedural …